A method for detecting apnea by sampling a voltage waveform representative of respiration at regular intervals and calculating the instantaneous voltage differences at alternate sample points, and comparing the magnitude of each difference voltage so calculated against a "threshold" value determined to be the minimum value consistent with normal respiration activity.

Patent
   4365636
Priority
Jun 19 1981
Filed
Jun 19 1981
Issued
Dec 28 1982
Expiry
Jun 19 2001
Assg.orig
Entity
Large
221
1
EXPIRED
1. A method of monitoring waveforms indicative of patient respiration and activating an alarm upon occurrence of predetermined respiration conditions indicative of apnea, comprising the steps of
(a) monitoring a respiration waveform and forming a value representative of the instantaneous magnitude of said waveform at regular and continuous time intervals;
(b) continuously forming the difference between each such value and at least the second previous such value, and developing therefrom a value representative of the instaneous slope of said waveform;
(c) collecting such slope values for a first predetermined time which is at least as long in time as one respiration cycle and selecting from the collected slope values the maximum collected slope value;
(d) continuously repeating step (c) for a second predetermined time which is longer than said first predetermined time, and forming the average of all maximum collected slope values;
(e) forming a threshold value by selecting a predetermined fraction of said average of step (d);
(f) comparing subsequent slope valves as found in step (b) with said threshold value of step (e) and activating said alarm when said subsequent slope values are less than the threshold value of step (e) for longer than a third predetermined time.
12. A method of monitoring patient respiration waveforms and activating an audible alarm upon occurrence of predetermined respiration conditions indication of apnea, comprising
(a) sampling a respiration waveform at a predetermined sampling rate and recording instantaneous waveform magnitude values obtained from such sampling;
(b) subtracting recorded instantaeous magnitude values from previously recorded instantaneous magnitude values and developing therefrom values representative of instantaneous rate of change of respiration;
(c) selecting the maximum rate of change value occurring over a first predetermined time period which is at least as long as one respiration cycle;
(d) continuously repeating step (c) for a second predetermined time period which is longer than said first time period and accumulating the selected maximum rate of change values over said first and second predetermined time periods;
(e) averaging the accumulated maximum rate of change values and forming a threshold value by developing a value which is a predetermined fraction of said averaged values, said fraction being less than one;
(f) comparing said threshold value against subsequent values representative of instantaneous rate of change of respiration as developed in step (b); and
(g) activating an alarm whenever said threshold value exceeds said values representative of instantaneous rate of change of respiration for a third predetermined time interval.
2. The method of claim 1, wherein said regular and continuous time intervals of step (a) are at least 8 times per second.
3. The method of claim 1, wherein the values developed in step (b) are converted to absolute magnitude values.
4. The method of claim 1, wherein said first predetermined time is at least four seconds.
5. The method of claim 1, wherein said second predetermined time is at least two minutes.
6. The method of claim 1, wherein said predetermined fraction is 174 .
7. The method of claim 1, wherein said third predetermined time is in the range of ten to thirty seconds.
8. The method of claim 2, wherein said first predetermined time is at least four seconds.
9. The method of claim 8, wherein said second predetermined time is at least two minutes.
10. The method of claim 9, wherein said predetermined fraction is 1/4.
11. The method of claim 10, wherein said third predetermined time is in the range of ten to thirty seconds.
13. The method of claim 12, wherein said predetermined sampling rate is at least 8 samples per second.
14. The method of claim 12, wherein said step of subtracting further comprises subtracting a recorded instantaneous respiration value from a second previous recorded instantaneous respiration value.
15. The method of claim 12, wherein said first predetermined time interval is at least four seconds.
16. The method of claim 12, wherein said second predetermined time interval is at least two minutes.
17. The method of claim 12, wherein said predetermined fraction is substantially 1/4.
18. The method of claim 12, wherein said third predetermined time interval is in the range of ten to thirty seconds.
19. The method of claim 13, wherein said step of subtracting further comprises subtracting a recorded instantaneous magnitude value from a second previous recorded instantaneous magnitude value.
20. The method of claim 14, wherein said first predetermined time interval is at least four seconds.
21. The method of claim 15, wherein said second predetermined time interval is at least two minutes.
22. The method of claim 16, wherein said predetermined fraction is substantially 1/4.
23. The method of claim 17, wherein said third predetermined time interval is in the range of ten to thirty seconds.

This invention relates to a method for monitoring patient respiration; more particularly, the invention relates to a method for monitoring patient respiration by evaluation of an electrical signal generated by an electrode coupled to the patient during respiration. The invention is primarily intended for respiration monitoring and analysis in furtherance of the detection and prediction of apnea.

The medical term "apnea" means cessation of respiration or breathing. The apneic condition has become associated in recent years with the "sudden infant death syndrome", wherein a disturbing pattern of early deaths of apparently healthy infants were noted. Studies and research programs have been conducted by agencies of the federal government and others in an attempt to identify the cause of sudden infant death syndrome, and such studies have revealed that infants who are subject to this syndrome are apparently not the healthy infants before death that they were once believed to be. These infants appear to have subtle and anatomic and physiological defects of a neurologic, cardiorespiratory and/or metabolic nature. There has developed evidence that the syndrome is not caused by a single mechanism working at one moment in time, but rather by a number of developmental, environmental, and pathologic factors which become involved in complex interactions and circumstances to set up a sequence of events that produces the sudden, unexpected and unexplained infant death. Much of this research has revolved around the hypothesis that apnea during sleep is related to the syndrome. It has also been postulated that apneic episodes during sleep which do not necessarily lead to sudden infant death may lead to aberrations in central nervous system development. There is evidence that with infants having numerous apneic episodes during sleep, the resulting inadequate oxygen supply to the brain may lead to retardation of brain development, which in turn may lead to further loss of respiratory control and further apneic problems.

Apnea may be caused by a number of other factors not necessarily related to conditions of infants, some of which are spinal cord injury, muscular dystrophy, lung diseases, drug intoxication, and certain other risk factors which have become apparent in aid of the identification of those who might be candidates or may suffer higher than normal risk for incurring apneic events. In adults, a history of heavy snoring denotes an individual at risk to apnea, especially in combination with other such factors as obesity, underlying heart desease and/or high blood pressure.

Whereas apneic conditions may be monitored in hospital and laboratory environments by means of suitably connected electrodes to a patient's body, and monitoring of a cathode ray tube (CRT) display which exhibits a wave form related to patient respiration, such monitoring is impractical or impossible in less controlled environments. There is therefore a need for techniques and devices which will enable appropriate monitoring of adults or infants and which will detect apneic conditions in time to set off an alarm in order that the condition may be corrected. For sleeping patients, it is frequently only necessary to wake the patient by means of an audible alarm or other alarm indication in order that the patient may become conscious and resume normal breathing. It is therefore important that techniques and devices be developed for utilization in conjunction with sleeping individuals, in order that apneic episodes may be detected and corrected before physiological damage or harm occurs. In all events, the detection of apnea requires a monitoring of respiration and/or heart rates. Such monitoring is accomplished by means of the attachment or coupling of suitable electrodes or other transducer devices to the patient, so that signals developed by such devices may be transmitted to circuitry for detection and analysis. Monitoring transducers are well-known in the art, as for example the respiration monitoring apparatus described in U.S. Pat. No. 3,760,794, issued Sept. 25, 1973. This device is a capacitor transducer constructed from alternate layers of conductive and nonconductive materials which are placed beneath a patient in a mattress or other resilient support, and which detects motion caused by respiration. In other devices, electrodes are attached to the body to detect changes in body impedance or resistance as respiration occurs. In still other devices, pressure sensing transducers are used in the chest and/or stomach area of the body to detect pressure changes which occur as body movement occurs during respiration. All of these transducers, as well as other similar devices, monitor a physical parameter which is correlated with respiration, convert the parameter monitored into an equivalent electrical signal, and feed this signal into appropriate circuitry whose ultimate function is to note the occurance of a respiration cycle and to perform such other functions as are deemed necessary.

It is a general object of this invention to provide a method and process for the analysis of electrical signals representative of respiration, for the purpose of detecting and predicting apnea. It is a further object of the present invention to provide a method for analyzing respiration wave forms, for setting an alarm condition upon the detection of an apneic episode.

It is another object of the invention to provide a method for analyzing respiration waveforms and for detecting apnea, wherein the method and detection parameters self adjust for changing conditions of respiration.

The invention includes the step of sampling voltages representative of respiration at a predetermined and constant rate, and collecting a plurality of voltage points therefrom; the step of calculating waveform slope by utilizing collected voltage points separated by at least one sample interval; the step of comparing the slope so calculated against a predetermined threshold value which itself has been determined from monitoring of the respiration waveform; and the step of setting an alarm condition whenever the compared slopes remain less than the threshold value for a predetermined length of time.

An important and preliminary part of the invention is the process for developing a threshold value from observation and analysis of respiration waveforms. This portion of the invention involves the steps of calculating wave form slope values for a predetermined length of time, which time is longer than the time necessary for at least one respiration cycle; selecting the maximum slope value obtained over the predetermined time; repeating these steps for a predetermined longer time, which longer time approaches a steady state respiration condition; averaging all of the collected slope values to calculate a "bench mark" slope value; determining a threshold value which is a predetermined fraction of the "bench mark" slope value, the fraction being large enough to detect respiration activity which is representative of an apneic condition and small enough to ignore respiration activity considered representative of a non-apneic condition.

FIG. 1 shows a typical respiration waveform;

FIG. 2 shows a respiration waveform with periodic voltage sampling; and

FIG. 3 shows a plot of the slopes of pertinent points of FIG. 2; and

FIGS. 4A and 4B shows a flow chart of the method; and

FIG. 5 shows a diagram of an apparatus for performing the method.

Referring first to FIG. 1, there is shown a waveform which is representative of respiration activity as may typically be found in monitoring equipment known in the art. This waveform may be produced by electrical sensors attached directly to the body, or by pressure transducers coupled to the body in one or more of a number of ways. The characteristics of this wave form make it exceedingly difficult to analyze with automatic and unattended electronic or other equipment, whereas a trained technician can readily understand and analyze the waveform while observing it on a cathode ray (CRT) display device. This form of analysis has been widely used in the past, but unfortunately requires the technician to constantly monitor a CRT device in order to detect an apneic condition when one occurs. Some of the waveform parameters which heretofore have defied proper automatic analysis are as follows:

1. The respiration waveform amplitude A, when measured from any arbitrary baseline B, may fluctuate widely and unpredictably during both "normal" respiratory activity and "abnormal" respiration activity;

2. The waveform peak to peak amplitude P may fluctuate widely over all forms of respiration activity;

3. The waveform period T may range over very wide time values from one patient to another, and with respect to a single patient from one time to another; and

4. The waveform shape itself is nonsinusoidal, and therefore requires empirical simplification in order to relate it to normal sinusoidal mathematical treatment, but such empirical simplification must reasonably approximate actual respiration activity so as to provide valid detection without false alarms.

Any method of automatic analysis of the complex waveform of FIG. 1 must therefore take into account all of the variable parameters summarized above, and must also be capable of adapting to real time changes in these parameters such as typically occur during sleep and nonsleep patient activity. For example, a patient while sleeping may undergo periods of deep breathing, followed by subsequent periods of very shallow breathing at higher respiration rates, all of which may be intermittently interrupted by deep sighs or other respiration activity.

It has been empirically determined that respiration rates vary from a high of about two respirations per second to a low of about one respiration per six seconds, and that practically all patients will have respiration rates falling within these bounds. Since the present method contemplates a digital measuring technique, wherein instantaneous waveform magnitudes are sampled at discreet and regular time intervals, the minimum number of such samples necessary for obtaining valid information is therefore governed by the fastest respiration rate. A sampling rate of eight samples per second has been empirically determined to be adequate for obtaining sufficient data points on even the fastest respiration waveform for useful results. Of course, the sample rate could be set higher than eight samples per second to obtain correspondingly more data points, and requiring additional processing of the data so obtained, but it has been determined that eight samples per second gives a reasonable result with a minimum number of data points even at the fastest respiration rates.

It has been empirically determined that a respiration waveform differs in several important characteristics from a pure sinusoidal waveform. Respiration waveforms contain high frequency components which tend to generate a steeper, higher rate amplitude waveform than the comparable pure sinusoidal waveform. For example, it has been determined that the ratio of the maximum waveform slope to the peak waveform amplitude is approximately 1.4 times greater than the same values for a pure sinusoid. Thus, if one is to use this ratio as the base measurement for determining whether the apneic condition exists, and for selecting a threshold value below which an alarm condition should be set, one must select a different threshold level for a respiration waveform than would be selected for a pure sinusoidal waveform. It has been determined that a threshold value of one-half the pure sinusoidal threshold value is required for adequate operation of the method.

The threshold value must be selected low enough such that a wide range of normal respiration waveforms are detected as respiration and not apnea. On the other hand, the threshold must be high enough to prevent false respiration indications during apnea. Since the slowest respiration waveform empirically measured is ten respirations per minute, this is the waveform which forms the basis for selecting the threshold value. This waveform can be represented by a sinusoid having a period of six seconds, and for this waveform it can be shown that selection of a threshold equal to one-half of the peak sinusoidal value will result in values below threshold occurring for no longer than one second. Translating these results to the nonsinusoidal respiration waveform, it has been found that the threshold must be reduced by fifty percent in order for the same relationship to hold; namely, a respiration waveform of six seconds in duration will exhibit no more than one second of time below the threshold value if the threshold value is selected to be 0.25 times the peak value.

FIG. 2 shows a portion of a respiration waveform having discreet sampling intervals related thereto. Waveform points 20, 21, 22, . . . 39, each represent an instantaneous voltage magnitude obtained by voltage sampling the waveform at a regular sampling rate. Since the sampling rate is uniform, a representation of the slope of any line segment between any two points may be made by merely subtracting the magnitudes of the voltages at these points. In the preferred method, the slope is calculated between points spaced apart by at least one measurement interval, in order to minimize the effects of noise upon the sample points. For example, the voltage magnitude at 25 is subtracted from the voltage magnitude at 27, and this subtraction provides a measure of the slope of the line segment joining these two points. This slope may be represented as occurring at 26. Similarly, the voltage magnitude at 26 is subtracted from the voltage magnitude at 28, and this difference represents the slope at 27. FIG. 3 illustrates the slopes so represented at the various sample points of the waveform illustrated in FIG. 2. The maximum slope of this waveform is represented on FIG. 3 at 135. Note, that since the present method is concerned only with the magnitude of the slope the negative direction of the slope should be disregarded.

The preliminary method steps required for the practice of the method herein described involve the determination of a "threshold" slope value. This is accomplished by the steps illustrated in FIGS. 2 and 3, wherein the process is continued for a time period of four seconds. The maximum slope obtained during this four second time interval is determined and retained, and the cycle is repeated for thirty-one additional four second time intervals. After this time, thirty-two different maximum slope values have been retained, and the average of these thirty-two values is calculated to determine a "bench mark" slope value. The "bench mark" slope value is multiplied by 0.25 to set the "threshold" slope value. The "threshold" slope value is used as described hereinafter for constantly monitoring and detecting for the apnea condition.

However, a new "threshold" value is calculated approximately every two minutes so that major variations in patient respiration can be followed.

There are several exceptions to the step of periodically recalculating the "threshold" value. One of these is when an apnea event is detected during any four-second interval, in which case no maximum slope is calculated for that interval. A second exception occurs during any two minute interval wherein the average "bench mark" value exceeds the value calculated during the previous two minute interval by more than 1.5. In this case, it is assumed that a temporary abnormal respiration event has occurred, which event may be a sigh or moment of deep breathing, but which is not related to apnea or to so-called "normal" breathing patterns. In this event the "bench mark" is set at 1.5 times the "bench mark" previously calculated for the previous two minute interval, and is maintained at this calculated level until a new calculation is made.

Having determined a "threshold" value according to the steps hereinbefore described, this value is used to determine whether the likelihood of an apnea event is occurring. As the normal sampling continues during respiration, and the calculation of waveform slopes continues, each of the slopes so calculated is compared against the "threshold" value. If any slope so calculated is less than the threshold value for three consecutive seconds, a probable apnea condition may be occurring. If such slopes continue for a selectable time period after this three second interval an alarm is set to indicate an apnea event. The alarm may be either a visual or audible alarm, but in the case of an unattended patient it is advisable to have an audible alarm. The sound of an alarm should be sufficient to awake the patient, and once the patient awakens the apnea event will cease. Since interrupted breathing in infants is not usually considered to be apnea until the duration extends to about 20 seconds, the selectable time interval which is chosen for indicating an alarm condition is normally set in the 10-30 second range.

Referring next to FIG. 4, there is shown a flow chart of the method steps. The method is started by manual intervention of an operator and proceeds thereafter automatically until an apnea alarm condition is noted. It is presumed that the necessary and other electrical and other connections have been made to a patent monitoring device, and the method then proceeds through the performance of a number of steps of analysis and treatment of the electronic waveform produced by the monitor device, which waveform is representative of patient respiration. The waveform is sampled at uniform time intervals, which in the preferred embodiment is chosen to be eight samples per second. Each sample produces a value representative of the instantaneous waveform value at the time of the sample. Initially, two samples are required in order to enter into the overall method steps, each of the two samples being stored or retained as instantaneous respiration values. After two samples have been stored, the second previous value is subtracted from the current sample value, and this difference is converted to a number representative of an absolute value slope. During the first thirty-two times the method is performed, the maximum slope value is selected as a bench mark slope, and a threshold value is calculated by multiplying the bench mark by 0.25. Thereafter, this threshold value is updated approximately every two minutes by retaining the maximum slope values for four-second intervals over this two-minute period, and averaging the maximum slopes for the entire two-minute period.

After the method has been performed for a time period in excess of two minutes, there is retained a current threshold value which is utilized in a comparison with each subsequent slope value. If, in this comparison, the current slope value is greater than the current threshold value, normal respiration activity is presumed and the apnea timer is disabled. If the current slope value is less than the current threshold value, and if this condition has persisted for longer than two seconds, the apnea timer is set. The apnea timer therefore begins a timed runout, the duration of which is compared against a preset time, and when the timed runout equals the preset time the alarm is sounded and awakens the patient.

After the comparison of the current slope with the current threshold value the method proceeds through an updating sequence to adjust the threshold value if circumstances require. The maximum slope occurring over a four-second period is retained, and collected along with the maximum slopes occurring over thirty-two such four-second periods. These thirty-two maximum slope values are then averaged to derive an average maximum slope over approximately a two-minute period, and a threshold value is calculated by multiplying this value by 0.25. This threshold value is then utilized as a comparison base for further comparisons with current value slopes during the next subsequent two-minute time period.

The sequence shown in FIG. 4 is repeated eight times per second, the various loops illustrated on the flow chart being activated according to the conditions encountered during each repeat of the sequence. Special conditions described hereinbefore are not included on the flow chart, it being apparent when such special conditions are executed.

FIG. 5 shows a symbolic diagram of an apparatus for performing the method. An analog to digital converter (A/D) 101 is connected to receive the electrical signal from the patient monitor. A clock 102 produces timing pulses at the rate of eight pulses per second, and is coupled to gate 103. When a timing signal is applied to gate 103, the digital value representative of respiration waveform is gated into a difference network 106. Difference network 106 receives the second previous value from storage 108, and forms the difference between the current value and the second previous value. This difference value is transferred over line 107 to a comparison network 110, the other input being fed into comparison network 110 being a signal over 109 repesentative of current threshold value. The current threshold value is also retrieved from storage 108. In the event the current slope value is less than the current threshold value, line 112 into time 116 is activated, thereby starting timer 116. In the event the current slope is not less than the current threshold value line 114 into timer 116 is activated, thereby resetting timer 116 to zero. The output of timer 116 is fed into a gate 118, which gate also has as an input a signal over line 119 from timer preset 120. When timer 116 has run sufficiently long to equal or exceed the value set into timer preset 120, gate 118 becomes enabled and a signal is sent to activate alarm 125. Alarm 125 may be an audible alarm or visual alarm or combination thereof. Alarm 125 preferably includes an audible alarm, the loudness of which is preferably great enough to awaken the patient. It is known that an apnea condition which occurs during sleep may be terminated by merely awakening the patient, and alarm 125 serves this purpose.

In operation, the method is performed on a continuing and recurring basis after the preliminary setup steps are accomplished. First, the patient is connected to a monitoring device through suitable electrodes or transducers. Next, the patient is visably monitored to ascertain that a more or less steady state respiration condition exists. The patient monitoring apparatus is connected to the apparatus for performing the method, and the method is performed for at least a two minute period to permit the development of a first threshold value. Thereafer, the method is automatically performed at regular intervals until and unless an apnea condition is detected according to the teachings of the method. In this event, an audible and/or visual alarm is set and the method is terminated. Alternatively, the method may be continued even after detecting and indicating an alarm condition, by merely resetting the apnea timer and continuing the sequence described herein.

The present invention may be embodied in other specific forms without departing from the spirit or essential attributes thereof, and it is therefore desired that the present embodiment be considered in all respects as illustrative and not restrictive, reference being made to the appended claims rather than to the foregoing description to indicate the scope of the invention.

Barker, Kent R.

Patent Priority Assignee Title
10022548, Aug 07 2007 Cardiac Pacemakers, Inc. Method and apparatus to perform electrode combination selection
10046133, Apr 02 2009 BREATHE TECHNOLOGIES, INC Methods, systems and devices for non-invasive open ventilation for providing ventilation support
10058269, Feb 10 2006 Monitoring system for identifying an end-exhalation carbon dioxide value of enhanced clinical utility
10058668, May 18 2007 BREATHE TECHNOLOGIES, INC Methods and devices for sensing respiration and providing ventilation therapy
10080901, Aug 07 2007 Cardiac Pacemakers, Inc. Method and apparatus to perform electrode combination selection
10099028, Aug 16 2010 BREATHE TECHNOLOGIES, INC Methods, systems and devices using LOX to provide ventilatory support
10232136, Apr 02 2009 BREATHE TECHNOLOGIES, INC Methods, systems and devices for non-invasive open ventilation for treating airway obstructions
10252020, Oct 01 2008 BREATHE TECHNOLOGIES, INC Ventilator with biofeedback monitoring and control for improving patient activity and health
10265486, Sep 03 2009 BREATHE TECHNOLOGIES, INC Methods, systems and devices for non-invasive ventilation including a non-sealing ventilation interface with an entrainment port and/or pressure feature
10512429, Dec 23 2004 ResMed Pty Ltd Discrimination of cheyne-stokes breathing patterns by use of oximetry signals
10532170, Mar 24 2008 Covidien LP Method and system for classification of photo-plethysmographically detected respiratory effort
10695519, Apr 02 2009 BREATHE TECHNOLOGIES, INC Methods, systems and devices for non-invasive open ventilation with gas delivery nozzles within nasal pillows
10709864, Apr 02 2009 BREATHE TECHNOLOGIES, INC Methods, systems and devices for non-invasive open ventilation with gas delivery nozzles with an outer tube
10792449, Oct 03 2017 BREATHE TECHNOLOGIES, INC Patient interface with integrated jet pump
10898142, Dec 12 2003 Cardiac Pacemakers, Inc. Cardiac response classification using retriggerable classification windows
11077267, Dec 21 2010 Fisher & Paykel Healthcare Limited Pressure adjustment method for CPAP machine
11089994, Nov 26 2007 WhisperSom Corporation Device to detect and treat apneas and hypopnea
11103667, Apr 02 2009 Breathe Technologies, Inc. Methods, systems and devices for non-invasive ventilation with gas delivery nozzles in free space
11129949, Aug 06 2004 Fisher & Paykel Healthcare Limited Autotitrating method and apparatus
11154672, Sep 03 2009 Breathe Technologies, Inc. Methods, systems and devices for non-invasive ventilation including a non-sealing ventilation interface with an entrainment port and/or pressure feature
11246501, Apr 15 2016 Omron Corporation; OMRON HEALTHCARE CO , LTD Biological information analysis device, system, and program
11363961, Apr 15 2016 Omron Corporation; OMRON HEALTHCARE CO , LTD Biological information analysis device, system, and program
11439321, Feb 10 2006 Monitoring system for identifying an end-exhalation carbon dioxide value of enhanced clinical utility
11617516, Apr 15 2016 Omron Corporation; OMRON HEALTHCARE CO , LTD Biological information analysis device, biological information analysis system, program, and biological information analysis method
11744968, Dec 21 2010 Fisher & Paykel Healthcare Limited Pressure adjustment method for CPAP machine
11813078, Nov 26 2007 WhisperSom Corporation Device to detect and treat apneas and hypopnea
11857795, Aug 07 2007 Cardiac Pacemakers, Inc. Method and apparatus to perform electrode combination selection
11896388, Dec 23 2004 ResMed Pty Ltd Method for detecting and discriminating breathing patterns from respiratory signals
11896766, Apr 02 2009 Breathe Technologies, Inc. Methods, systems and devices for non-invasive ventilation with gas delivery nozzles in free space
11986658, Nov 04 2020 INVICTA MEDICAL, INC Implantable electrodes with remote power delivery for treating sleep apnea, and associated systems and methods
12161807, Apr 02 2009 Breathe Technologies, Inc. Methods, systems and devices for non-invasive open ventilation with gas delivery nozzles within nasal pillows
4686999, Apr 10 1985 INTERNATIONAL ADAPTIVE MONITORS, INC Multi-channel ventilation monitor and method
4757815, Dec 20 1985 Siemens Aktiengesellschaft Heart pacemaker
4757824, Aug 21 1985 KONTRON INSTRUMENTS HOLDING N V Method and apparatus for monitoring respiration
4803997, Jul 14 1986 CAS Medical Systems, INC Medical monitor
4830008, Apr 24 1987 JEFFREY A MEER REVOCABLE LIVING Method and system for treatment of sleep apnea
4860766, Nov 18 1983 NON-INVASIVE MONITORING SYSTEMS, INC Noninvasive method for measuring and monitoring intrapleural pressure in newborns
5107831, Jun 19 1989 BEAR MEDICAL SYSTEMS INC Ventilator control system using sensed inspiratory flow rate
5203343, Jun 14 1991 UNIVERSITY OF TEXAS SYSTEM, THE Method and apparatus for controlling sleep disorder breathing
5206807, Feb 16 1989 HILL-ROM AIR-SHIELDS, INC Neonatal cardiorespirograph incorporating multi-variable display and memory
5226416, Jun 16 1988 Pneu Pac Limited Monitoring and alarm apparatus
5295490, Jan 21 1993 Self-contained apnea monitor
5335654, May 07 1992 New York University Method and apparatus for continuous adjustment of positive airway pressure for treating obstructive sleep apnea
5398682, Aug 19 1992 Method and apparatus for the diagnosis of sleep apnea utilizing a single interface with a human body part
5535739, May 20 1994 New York University; Nellcor Puritan Bennett Method and apparatus for optimizing the continuous positive airway pressure for treating obstructive sleep apnea
5540733, Sep 21 1994 INSPIRE MEDICAL SYSTEMS, INC Method and apparatus for detecting and treating obstructive sleep apnea
5546933, May 07 1992 New York University Method for optimizing the continuous positive airway pressure for treating obstructive sleep apnea
5549106, May 19 1989 Nellcor Puritan Bennett Incorporated; Nellcor Puritan Bennett LLC Inspiratory airway pressure system using constant pressure and measuring flow signals to determine airway patency
5549113, Nov 09 1992 ILIFE SOLUTIONS, INC Apparatus and method for remote monitoring of physiological parameters
5605151, Aug 19 1992 Method for the diagnosis of sleep apnea
5645053, Nov 14 1991 UNIVERSITY TECHNOLOGIES INTERNATIONAL, INC Auto CPAP system and method for preventing patient disturbance using airflow profile information
5685318, Sep 29 1995 Draeger Medical Systems, Inc Method and apparatus for detecting quick movement artifact in impedance respiration signals
5782240, Dec 22 1994 SNAP DIAGNOSTICS LLC Method of classifying respiratory sounds
5803066, May 07 1992 New York University Method and apparatus for optimizing the continuous positive airway pressure for treating obstructive sleep apnea
5879313, Dec 12 1994 SNAP DIAGNOSTICS LLC Method of classifying respiratory sounds
5891023, Aug 19 1992 Apparatus for the diagnosis of sleep apnea
5895360, Jun 26 1996 Medtronic, Inc. Gain control for a periodic signal and method regarding same
5944680, Jun 26 1996 Medtronic, Inc. Respiratory effort detection method and apparatus
5961447, Apr 21 1994 SNAP DIAGNOSTICS LLC Method of analyzing sleep disorders
6014578, Aug 06 1998 Medtronic, Inc Ambulatory recorder having method of configuring size of data subject to loss in volatile memory
6029665, Nov 05 1993 ResMed Limited Determination of patency of airway
6041780, Jun 07 1995 Nellcor Puritan Bennett LLC Pressure control for constant minute volume
6045514, Dec 22 1994 SNAP DIAGNOSTICS LLC Method of measuring breathing resistance of a sleeping subject
6059725, Aug 05 1997 American Sudden Infant Death Syndrome Institute Prolonged apnea risk evaluation
6077223, Aug 06 1998 Medtronic, Inc Ambulatory recorder having control screen to present dual interface for dual users
6115622, Aug 06 1998 Medtronic, Inc Ambulatory recorder having enhanced sampling technique
6119029, Aug 06 1998 Medtronic, Inc Ambulatory recorder having splash resistant sensor ports
6128520, Aug 06 1998 Medtronic, Inc Ambulatory recorder having volatile and non-volatile memories
6129675, Sep 11 1998 JPMorgan Chase Bank, National Association Device and method for measuring pulsus paradoxus
6138675, Nov 05 1993 Resmed Ltd. Determination of the occurrence of an apnea
6141574, Aug 06 1998 Medtronic, Inc Ambulatory recorder having sliding period switches
6142938, Aug 06 1998 Medtronic, Inc Ambulatory data recorder having ergonomically shaped housing
6154668, Aug 06 1998 Medtronic, Inc Ambulatory recorder having a real time and non-real time processors
6200264, Aug 06 1998 Medtronic, Inc Ambulatory recorder having wireless data transfer with a multi-plane lens
6212435, Nov 13 1998 RIC Investments, LLC Intraoral electromuscular stimulation device and method
6223064, Aug 19 1992 LYNN, LAWRENCE A Microprocessor system for the simplified diagnosis of sleep apnea
6245013, Dec 14 1998 Medtronic, Inc Ambulatory recorder having synchronized communication between two processors
6283119, Jun 15 1992 Covidien AG Breathing aid apparatus in particular for treating sleep apnoea
6299581, May 07 1992 New York University; Puritan Bennett Corporation Method and apparatus for optimizing the continuous positive airway pressure for treating obstructive sleep apnea
6325761, Sep 11 1998 JPMorgan Chase Bank, National Association Device and method for measuring pulsus paradoxus
6342039, Aug 19 1992 Lawrence A., Lynn Microprocessor system for the simplified diagnosis of sleep apnea
6488634, May 07 1992 New York University Method and apparatus for optimizing the continuous positive airway pressure for treating obstructive sleep apnea
6550478, Nov 14 1991 University Technologies International, Inc. Auto CPAP system profile information
6618627, Nov 13 1998 RIC Investments, LLC Intraoral electromuscular stimulating device and method
6748252, Aug 19 1992 System and method for automatic detection and indication of airway instability
6760608, Nov 15 1993 Lawrence A., Lynn Oximetry system for detecting ventilation instability
6793629, May 07 1992 New York University; Puritan-Bennett Corporation Method and apparatus for optimizing the continuous positive airway pressure for treating obstructive sleep apnea
6866040, Sep 12 1994 Nellcor Puritan Bennett LLC Pressure-controlled breathing aid
6920877, Nov 14 1991 University Technologies International, Inc. Auto CPAP system profile information
7081095, May 17 2001 Centralized hospital monitoring system for automatically detecting upper airway instability and for preventing and aborting adverse drug reactions
7153278, Aug 22 2003 Kabushiki Kaisha Sato Sleep apnea syndrome diagnosing device and signal analyzer, and methods thereof
7189204, Dec 04 2002 Cardiac Pacemakers, Inc Sleep detection using an adjustable threshold
7320320, Nov 05 1993 ResMed Limited Determination of patency of the airway
7336996, Sep 18 2003 Cardiac Pacemakers, Inc Rate regularization of cardiac pacing for disordered breathing therapy
7371220, Jun 30 2004 Pacesetter, Inc. System and method for real-time apnea/hypopnea detection using an implantable medical system
7396333, Aug 18 2003 Cardiac Pacemakers, Inc Prediction of disordered breathing
7398115, Aug 19 1992 Pulse oximetry relational alarm system for early recognition of instability and catastrophic occurrences
7468040, Sep 18 2003 Cardiac Pacemakers, Inc. Methods and systems for implantably monitoring external breathing therapy
7469697, Sep 18 2003 Cardiac Pacemakers, Inc Feedback system and method for sleep disordered breathing therapy
7510531, Sep 18 2003 Cardiac Pacemakers, Inc System and method for discrimination of central and obstructive disordered breathing events
7532934, Sep 18 2003 Cardiac Pacemakers, Inc. Snoring detection system and method
7572225, Sep 18 2003 Cardiac Pacemakers, Inc Sleep logbook
7575553, Sep 18 2003 Cardiac Pacemakers, Inc. Methods and systems for assessing pulmonary disease
7591265, Sep 18 2003 Cardiac Pacemakers, Inc. Coordinated use of respiratory and cardiac therapies for sleep disordered breathing
7610094, Sep 18 2003 Cardiac Pacemakers, Inc Synergistic use of medical devices for detecting medical disorders
7664546, Sep 18 2003 Cardiac Pacemakers, Inc Posture detection system and method
7668579, Feb 10 2006 System and method for the detection of physiologic response to stimulation
7668591, Sep 18 2003 Cardiac Pacemakers, Inc Automatic activation of medical processes
7678061, Sep 18 2003 Cardiac Pacemakers, Inc System and method for characterizing patient respiration
7680537, Aug 18 2003 Cardiac Pacemakers, Inc Therapy triggered by prediction of disordered breathing
7706852, Jan 30 2006 Covidien LP System and method for detection of unstable oxygen saturation
7711438, Nov 13 1998 RIC Investments, LLC Intraoral electromuscular stimulation device and method
7720541, Aug 18 2003 Cardiac Pacemakers, Inc Adaptive therapy for disordered breathing
7730886, Nov 05 1993 ResMed Limited Determination of patency of the airway
7747323, Jun 08 2004 Cardiac Pacemakers, Inc Adaptive baroreflex stimulation therapy for disordered breathing
7757690, Sep 18 2003 Cardiac Pacemakers, Inc System and method for moderating a therapy delivered during sleep using physiologic data acquired during non-sleep
7758503, Jan 27 1997 LYNN, LAWRENCE ALLAN Microprocessor system for the analysis of physiologic and financial datasets
7766830, Dec 27 2001 Medtronic MiniMed, Inc. System for monitoring physiological characteristics
7766842, Dec 04 2002 Cardiac Pacemakers, Inc. Detection of disordered breathing
7774064, Dec 12 2003 Cardiac Pacemakers, Inc Cardiac response classification using retriggerable classification windows
7787946, Sep 18 2003 Cardiac Pacemakers, Inc Patient monitoring, diagnosis, and/or therapy systems and methods
7882834, Aug 06 2004 Fisher & Paykel Healthcare Limited Autotitrating method and apparatus
7887493, Sep 18 2003 Cardiac Pacemakers, Inc Implantable device employing movement sensing for detecting sleep-related disorders
7901361, May 07 1992 New York University Method and apparatus for optimizing the continuous positive airway pressure for treating obstructive sleep apnea
7938782, Aug 18 2003 Cardiac Pacemakers, Inc. Prediction of disordered breathing
7967756, Sep 18 2003 Cardiac Pacemakers, Inc Respiratory therapy control based on cardiac cycle
7992557, Feb 12 1999 Covidien AG Gas supply device for sleep apnea
7993279, Sep 18 2003 Cardiac Pacemakers, Inc. Methods and systems for implantably monitoring external breathing therapy
8002553, Aug 18 2003 Cardiac Pacemakers, Inc Sleep quality data collection and evaluation
8066647, Dec 23 2004 ResMed Pty Ltd Method for detecting and discriminating breathing patterns from respiratory signals
8104470, Sep 18 2003 Cardiac Pacemakers, Inc. Coordinated use of respiratory and cardiac therapies for sleep disordered breathing
8136527, Aug 18 2003 BREATHE TECHNOLOGIES, INC Method and device for non-invasive ventilation with nasal interface
8145310, Dec 11 2003 Cardiac Pacemakers, Inc. Non-captured intrinsic discrimination in cardiac pacing response classification
8152732, May 17 2001 Microprocessor system for the analysis of physiologic and financial datasets
8185202, Apr 26 2005 Cardiac Pacemakers, Inc. Implantable cardiac device for reduced phrenic nerve stimulation
8187201, Jan 27 1997 System and method for applying continuous positive airway pressure
8209013, Sep 14 2006 Cardiac Pacemakers, Inc. Therapeutic electrical stimulation that avoids undesirable activation
8221327, Sep 18 2003 Cardiac Pacemakers, Inc. Therapy control based on cardiopulmonary status
8241213, Jan 27 1997 Microprocessor system for the analysis of physiologic datasets
8251061, Sep 18 2003 Cardiac Pacemakers, Inc. Methods and systems for control of gas therapy
8260421, Apr 26 2005 Cardiac Pacemakers, Inc. Method for reducing phrenic nerve stimulation
8265736, Aug 07 2007 Cardiac Pacemakers, Inc Method and apparatus to perform electrode combination selection
8275553, Feb 19 2008 Covidien LP System and method for evaluating physiological parameter data
8302602, Sep 30 2008 Covidien LP Breathing assistance system with multiple pressure sensors
8321022, Aug 18 2003 Cardiac Pacemakers, Inc. Adaptive therapy for disordered breathing
8323204, Dec 27 2002 Cardiac Pacemakers, Inc. Medical event logbook system and method
8360060, Nov 05 1993 ResMed Limited Distinguishing between closed and open airway apneas and treating patients accordingly
8365730, Mar 24 2008 Covidien LP Method and system for classification of photo-plethysmographically detected respiratory effort
8380296, Sep 18 2003 Cardiac Pacemakers, Inc. Automatic activation of medical processes
8381722, Nov 05 1993 ResMed Limited Distinguishing between closed and open airway apneas and treating patients accordingly
8381729, Jun 18 2003 BREATHE TECHNOLOGIES, INC Methods and devices for minimally invasive respiratory support
8398555, Sep 10 2008 Covidien LP System and method for detecting ventilatory instability
8418694, Aug 11 2003 BREATHE TECHNOLOGIES, INC Systems, methods and apparatus for respiratory support of a patient
8442638, Jun 08 2004 Cardiac Pacemakers, Inc. Adaptive baroreflex stimulation therapy for disordered breathing
8515535, Feb 28 2005 Cardiac Pacemakers, Inc. Implantable cardiac device with dyspnea measurement
8521284, Dec 12 2003 Cardiac Pacemakers, Inc Cardiac response classification using multisite sensing and pacing
8522779, Sep 18 2003 Cardiac Pacemakers, Inc. Coordinated use of respiratory and cardiac therapies for sleep disordered breathing
8535222, Dec 04 2002 Cardiac Pacemakers, Inc. Sleep detection using an adjustable threshold
8567399, Sep 26 2007 BREATHE TECHNOLOGIES, INC Methods and devices for providing inspiratory and expiratory flow relief during ventilation therapy
8573206, Sep 12 1994 Covidien LP Pressure-controlled breathing aid
8573219, Aug 18 2003 BREATHE TECHNOLOGIES, INC Method and device for non-invasive ventilation with nasal interface
8600502, Aug 18 2003 Cardiac Pacemakers, Inc. Sleep state classification
8606356, Sep 18 2003 Cardiac Pacemakers, Inc Autonomic arousal detection system and method
8606357, May 28 2003 Cardiac Pacemakers, Inc. Cardiac waveform template creation, maintenance and use
8615297, Aug 07 2007 Cardiac Pacemakers, Inc. Method and apparatus to perform electrode combination selection
8649866, Feb 14 2008 Cardiac Pacemakers, Inc. Method and apparatus for phrenic stimulation detection
8677999, Aug 22 2008 BREATHE TECHNOLOGIES, INC Methods and devices for providing mechanical ventilation with an open airway interface
8728001, Feb 10 2006 Lawrence A., Lynn Nasal capnographic pressure monitoring system
8750992, Feb 28 2005 Cardiac Pacemakers, Inc. Implantable cardiac device with dyspnea measurement
8752547, Nov 05 1993 ResMed Limited Distinguishing between closed and open airway apneas and treating patients accordingly
8770193, Apr 18 2008 BREATHE TECHNOLOGIES, INC Methods and devices for sensing respiration and controlling ventilator functions
8776793, Apr 18 2008 BREATHE TECHNOLOGIES, INC Methods and devices for sensing respiration and controlling ventilator functions
8781753, Feb 19 2008 Covidien LP System and method for evaluating physiological parameter data
8831726, Dec 11 2003 Cardiac Pacemakers, Inc. Cardiac response classification using multiple classification windows
8843199, Dec 12 2003 Cardiac Pacemakers, Inc. Cardiac response classification using multisite sensing and pacing
8844537, Oct 13 2010 System and method for alleviating sleep apnea
8862196, May 17 2001 Lawrence A., Lynn System and method for automatic detection of a plurality of SP02 time series pattern types
8915741, Aug 18 2003 Cardiac Pacemakers, Inc. Sleep quality data collection and evaluation
8925545, Sep 26 2007 BREATHE TECHNOLOGIES, INC Methods and devices for treating sleep apnea
8932227, Jul 28 2000 Lawrence A., Lynn System and method for CO2 and oximetry integration
8936556, Sep 24 2008 Cardiac Pacemakers, Inc. Minute ventilation-based disordered breathing detection
8939152, Sep 30 2010 BREATHE TECHNOLOGIES, INC Methods, systems and devices for humidifying a respiratory tract
8954146, Feb 28 2005 Cardiac Pacemakers, Inc. Implantable cardiac device with dyspnea measurement
8955518, Jun 18 2003 BREATHE TECHNOLOGIES, INC Methods, systems and devices for improving ventilation in a lung area
8956295, Dec 04 2002 Cardiac Pacemakers, Inc. Sleep detection using an adjustable threshold
8983602, Aug 07 2007 Cardiac Pacemakers, Inc. Method and apparatus to perform electrode combination selection
8985099, May 18 2006 BREATHE TECHNOLOGIES, INC Tracheostoma spacer, tracheotomy method, and device for inserting a tracheostoma spacer
8996112, Feb 14 2008 Cardiac Pacemakers, Inc. Method and apparatus for phrenic stimulation detection
9008771, Dec 11 2003 Cardiac Pacemakers, Inc. Non-captured intrinsic discrimination in cardiac pacing response classification
9008775, Aug 07 2007 Cardiac Pacemakers, Inc. Method and apparatus to perform electrode combination selection
9014819, Sep 18 2003 Cardiac Pacemakers, Inc. Autonomic arousal detection system and method
9037239, Aug 07 2007 Cardiac Pacemakers, Inc. Method and apparatus to perform electrode combination selection
9042952, May 17 2001 Lawrence A., Lynn; LAWRENCE A LYNN System and method for automatic detection of a plurality of SPO2 time series pattern types
9044558, Mar 24 2008 Covidien LP Method and system for classification of photo-plethysmographically detected respiratory effort
9053222, May 17 2002 Lawrence A., Lynn; LYNN, LAWRENCE A Patient safety processor
9095265, Dec 22 2008 Cardiac Pacemakers, Inc. Cardiac waveform template creation, maintenance and use
9132250, Sep 03 2009 BREATHE TECHNOLOGIES, INC Methods, systems and devices for non-invasive ventilation including a non-sealing ventilation interface with an entrainment port and/or pressure feature
9149597, Aug 06 2004 Fisher & Paykel Healthcare Limited Autotitrating method and apparatus
9180270, Apr 02 2009 BREATHE TECHNOLOGIES, INC Methods, systems and devices for non-invasive open ventilation with gas delivery nozzles within an outer tube
9189941, Apr 14 2011 Koninklijke Philips Electronics N V Stepped alarm method for patient monitors
9227034, Apr 02 2009 BREATHE TECHNOLOGIES, INC Methods, systems and devices for non-invasive open ventilation for treating airway obstructions
9277885, Feb 28 2005 Cardiac Pacemakers, Inc. Implantable cardiac device with dyspnea measurement
9308375, Dec 12 2003 DIVERGENT TECHNOLOGIES, INC Cardiac response classification using multisite sensing and pacing
9352160, Feb 14 2008 Cardiac Pacemakers, Inc. Method and apparatus for phrenic stimulation detection
9358358, Sep 30 2010 BREATHE TECHNOLOGIES, INC Methods, systems and devices for humidifying a respiratory tract
9427588, Aug 07 2007 Cardiac Pacemakers, Inc. Method and apparatus to perform electrode combination selection
9468378, Jul 14 1998 Lawrence A., Lynn; LYNN, LAWRENCE A Airway instability detection system and method
9533160, Aug 07 2007 Cardiac Pacemakers, Inc. Method and apparatus to perform electrode combination selection
9539429, Aug 07 2007 Cardiac Pacemakers, Inc. Method and apparatus to perform electrode combination selection
9555253, Feb 14 2008 Cardiac Pacemakers, Inc. Method and apparatus for phrenic stimulation detection
9623252, Aug 07 2007 Cardiac Pacemakers, Inc. Method and apparatus to perform electrode combination selection
9649458, Sep 30 2008 Covidien LP Breathing assistance system with multiple pressure sensors
9675774, Apr 02 2009 BREATHE TECHNOLOGIES, INC Methods, systems and devices for non-invasive open ventilation with gas delivery nozzles in free space
9763767, Oct 13 2010 System and method for alleviating sleep apnea
9808202, Nov 28 2014 SHENZHEN NOVOCARE MEDICAL TECHNOLOGY CO , INC Mattress for measuring physiological parameters of heart
9814429, Sep 18 2003 Cardiac Pacemakers, Inc. System and method for discrimination of central and obstructive disordered breathing events
9872987, Jun 08 2004 Cardiac Pacemakers, Inc. Method and system for treating congestive heart failure
9962512, Apr 02 2009 BREATHE TECHNOLOGIES, INC Methods, systems and devices for non-invasive ventilation including a non-sealing ventilation interface with a free space nozzle feature
9993205, Dec 12 2003 Cardiac Pacemakers, Inc. Cardiac response classification using retriggerable classification windows
ER7812,
ER8466,
Patent Priority Assignee Title
4279257, Jul 25 1975 Electromagnetic field responder for respiration monitoring
//
Executed onAssignorAssigneeConveyanceFrameReelDoc
Jun 15 1981BARKER, KENT R MEDICON, INC 1760 SHELARD TOWER,WAYZATA BLVD & CO RD 18,MINNEAPOLIS,MN 55426 A CORP OF MN ASSIGNMENT OF ASSIGNORS INTEREST 0039140906 pdf
Jun 19 1981Medicon, Inc.(assignment on the face of the patent)
Date Maintenance Fee Events
Jul 30 1986REM: Maintenance Fee Reminder Mailed.
Oct 20 1986M170: Payment of Maintenance Fee, 4th Year, PL 96-517.
Oct 20 1986M176: Surcharge for Late Payment, PL 96-517.
Oct 24 1986ASPN: Payor Number Assigned.
Jun 28 1990M171: Payment of Maintenance Fee, 8th Year, PL 96-517.
Aug 02 1994REM: Maintenance Fee Reminder Mailed.
Dec 25 1994EXP: Patent Expired for Failure to Pay Maintenance Fees.


Date Maintenance Schedule
Dec 28 19854 years fee payment window open
Jun 28 19866 months grace period start (w surcharge)
Dec 28 1986patent expiry (for year 4)
Dec 28 19882 years to revive unintentionally abandoned end. (for year 4)
Dec 28 19898 years fee payment window open
Jun 28 19906 months grace period start (w surcharge)
Dec 28 1990patent expiry (for year 8)
Dec 28 19922 years to revive unintentionally abandoned end. (for year 8)
Dec 28 199312 years fee payment window open
Jun 28 19946 months grace period start (w surcharge)
Dec 28 1994patent expiry (for year 12)
Dec 28 19962 years to revive unintentionally abandoned end. (for year 12)